Ironshore Pharmaceuticals Inc.

NC · United States · Reporting entity ID 100000601811

Total reported 2019–2025

$7.73M

#573 of 2,960 reporting companies — 0% of all reported industry payments

$7.54M in general payments across 163,851 records, plus $194K in research funding across 20 records.

How it breaks down

General payments $7,539,980

Research funding $193,585

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.